EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece

Zoi Pournara, Emmanouela Kissandraki, Sevasti Koursioti, Manolis Linardakis, Emmanouil K Symvoulakis, Marilenna Anastasaki, Christos D Lionis, George Sourvinos

In Vivo · 2026

DOI: 10.21873/invivo.14276 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift In Vivo, 2026. Verfasst von Zoi Pournara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral, Antibodies, Neutralizing. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: The current study aimed to assess the levels of total IgG antibodies against the spike (S) and nucleocapsid (N) proteins of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as the neutralizing antibodies (nAbs) in a population of Crete, Greece. PATIENTS AND METHODS: In total, 1,061 participants with 2,081 follow-up measurements during May-December 2022, from eight different primary healthcare facilities, were categorized into four groups, based on vaccination and illness status. Blood samples were collected and processed to measure anti-S, anti-N and neutralizing antibodies. Based on specific cutoff values and using non-parametric methods, antibody levels were compared between different categories or disease/vaccination of SARS-CoV-2. RESULTS: The proportion of participants who had been infected was higher among the unvaccinated. Additionally, an increase in the number of vaccine doses administered resulted in a noteworthy reduction in the frequency of illness, with proportions decreasing from 69.2% among those who were not vaccinated or 83.1% among those vaccinated 1-2 times to 21.6% among those vaccinated 4+ times (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Antibodies, ViralAntibodies, NeutralizingHumansGreeceMaleFemaleSeroepidemiologic StudiesPrimary Health CareMiddle AgedImmunoglobulin GAdultAgedUnvaccinated PersonsSpike Glycoprotein, CoronavirusPhosphoproteinsCoronavirus Nucleocapsid ProteinsVaccinationCOVID-19 VaccinesYoung Adult

Stichwörter der Autor:innen

COVID-19neutralizing antibodiesnucleocapsid proteinspike proteintotal IgG antibodies

Substanzen

Antibodies, ViralAntibodies, NeutralizingImmunoglobulin GSpike Glycoprotein, CoronavirusPhosphoproteinsCoronavirus Nucleocapsid ProteinsCOVID-19 Vaccinesspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece.
  • Clinic of Social and Family Medicine, School of Medicine, University of Crete, Heraklion, Greece.
  • Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece; sourvino@med.uoc.gr.

Zitieren

APA

Pournara, Z., Kissandraki, E., Koursioti, S., Linardakis, M., Symvoulakis, E. K., Anastasaki, M., Lionis, C. D., & Sourvinos, G. (2026). Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece. In Vivo. https://doi.org/10.21873/invivo.14276

Vancouver

Pournara Z, Kissandraki E, Koursioti S, Linardakis M, Symvoulakis EK, Anastasaki M, et al. Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece. In Vivo. 2026. doi:10.21873/invivo.14276

BibTeX
@article{Pournara2026,
  author = {Pournara, Zoi and Kissandraki, Emmanouela and Koursioti, Sevasti and Linardakis, Manolis and Symvoulakis, Emmanouil K and Anastasaki, Marilenna and Lionis, Christos D and Sourvinos, George},
  title = {Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece},
  journal = {In Vivo},
  year = {2026},
  doi = {10.21873/invivo.14276}
}
Kostenlos starten →